Hypersensitivity reactions to non-steroidal anti-inflammatory drugs

Current Drug Metabolism

Volumn 10, Issue 9, 2009, Pages 971-980

  Cornejo Garcia, José Antonio ^a   Blanca López, Natalia ^b   Doña, Inmaculada ^a   Andreu, Inmaculada ^c   Agúndez, José A G ^d   Carballo, Miguel ^e   Blanca, Miguel ^a   Canto, María Gabriela ^b  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

^d UNIVERSITY OF EXTREMADURA   (Spain)

^e Tarrasa Hospital   (Spain)

Author keywords

Cross intolerance; Drug hypersensitivity; Immediate and non immediate reactions; NSAIDs

Indexed keywords

ACECLOFENAC; ACETYLSALICYLIC ACID; ALLOPURINOL; AMINE OXIDASE (COPPER CONTAINING); ANTICONVULSIVE AGENT; CELECOXIB; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; DIPYRONE; ETODOLAC; GLAFENINE; HISTAMINE METHYLTRANSFERASE; IBUPROFEN; INDOMETACIN; KETOPROFEN; MECLOFENAMIC ACID; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OXICAM DERIVATIVE; PARACETAMOL; PIROXICAM; PROPIONIC ACID DERIVATIVE; ROFECOXIB; SULFONAMIDE; SULINDAC; TENOXICAM; THIOMERSAL; UNINDEXED DRUG;

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; CLINICAL FEATURE; CONTACT DERMATITIS; COUGHING; DISEASE CLASSIFICATION; DISEASE SEVERITY; DNA POLYMORPHISM; DRESS SYNDROME; DRUG ERUPTION; DRUG EXPOSURE; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG USE; DYSPNEA; ENZYME ACTIVITY; EPIDERMOLYSIS; ERYTHEMA; FACE EDEMA; FEVER; FIXED DRUG ERUPTION; HEPATITIS; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOREACTIVITY; INCIDENCE; LUNG INFILTRATE; MACULOPAPULAR RASH; PHOTOALLERGY; PNEUMONIA; PRESCRIPTION; PREVALENCE; PRURITUS; REVIEW; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN ALLERGY; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; URTICARIA;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG HYPERSENSITIVITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERSENSITIVITY, DELAYED; HYPERSENSITIVITY, IMMEDIATE; MOLECULAR STRUCTURE; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 76749105616     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920009790711841     Document Type: Review

References (143)

1. Blanca, M.; Doña, I.; Torres, M.J.; Campo, P.; de Burgos, J.L.; Cornejo, J.A.; Rondon, C. Non steroids anti-inflammatory drugs (NSAIDs) intolerance versus allergy: patterns of response and drug involved. J. Allergy Clin. Immunol., 2009, 123, S239.
2. Roberts, L.J.; Morrow, J.D. In Goodman & Gilman's The pharmacological basis of therapeutics; Hardman, J.G.; Limbird, L.E., Ed; McGraw Hill: USA, 2001, pp. 687-731.
3. Johansson, S.G.; Bieber, T.; Dahl, R.; Friedmann, P.S.; Lanier, B.Q.; Lockey, R.F.; Motala, C.; Ortega Martell, J.A.; Platts-Mills, T.A.; Ring, J.; Thien, F.; Van Cauwenberge, P.; Williams, H.C. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J. Allergy Clin. Immunol., 2004, 113(5),832-836.
4. Canto, M.G.; Andreu, I.; Fernandez, J.; Blanca, M. Selective immediate hypersensitivity reactions to NSAIDs. Curr. Opin. Allergy Clin. Immunol., 2009, 9(4), 293-297.
5. Pichler, WJ. Delayed drug hypersensitivity reactions. Ann. Intern. Med., 2003, 139, 683-693.
6. Viola, M.; Quaratino, D.; Gaeta, F.; Rumi, G.; Caruso, C.; Romano, A. Cross-reactive reactions to nonsteroidal antiinflammatory drugs. Curr. Pharm. Des., 2008, 14(27):2826-2832.
7. Stevenson, D.D.; Sanchez-Borges, M.; Szczeklik, A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann. Allergy Asthma Immunol., 2001, 87(3), 177-180.
8. Roujeau, J.C.; Kelly, J.P.; Naldi, L.; Rzany, B.; Stern, R.S.; Anderson, T.; Auquier, A.; Bastuji-Garin, S.; Correia, O.; Locati, F.; Mockenhaupt, M.; Paoletti, C.; Shapiro, S.; Shear, N.; Schöpf, E.; Kaufman, D.W. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N. Engl. J. Med., 1995, 333(24), 1600-1607.
9. Levi, N.; Bastuji-Garin, S.; Mockenhaupt, M.; Roujeau, J.C.; Flahault, A.; Kelly, J.P.; Martin, E.; Kaufman, D.W.; Maison, P. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Pediatrics, 2009, 123(2), e297-304.
10. Mockenhaupt, M.; Kelly, J.P.; Kaufman, D.; Stern, R.S. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal antiinflammatory drugs: a multinational perspective. J. Rheumatol., 2003, 30(10), 2234-2240.
11. Jenkins, C.; Costello, J.; Hodge, L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ , 2004, 328(7437), 434.
12. Stevenson, D.D. Aspirin and NSAID sensitivity. Immunol. Allergy Clin. North Am., 2004, 24(3), 491-505, vii.
13. Gollapudi, R.R.; Teirstein, P.S.; Stevenson, D.D.; Simon, R.A. Aspirin sensitivity: implications for patients with coronary artery disease. JAMA, 2004, 292(24), 3017-3023.
14. Sanchez-Borges, M.; Capriles-Hulett, A.; Caballero-Fonseca, F. NSAID-induced urticaria and angioedema: a reappraisal of its clinical management. Am. J. Clin. Dermatol., 2002, 3(9), 599-607.
15. van Puijenbroek, E.P.; Egberts, A.C.; Meyboom, R.H.; Leufkens, H.G. Different risks for NSAID-induced anaphylaxis. Ann. Pharmacother., 2002, 36(1), 24-29.
16. van der Klauw, M.M.; Wilson, J.H.; Stricker, B.H. Drug-associated anaphylaxis: 20 years of reporting in The Netherlands (1974-1994) and review of the literature. Clin. Exp. Allergy, 1996, 26(12), 1355-1363.
17. Szczeklik, A. Analgesics, allergy and asthma. Drugs, 1986, 32(Suppl 4), 148-163.
18. Gómez, E.; Blanca-Lopez, N.; Torres, M.J.; Requena, G.; Rondon, C.; Canto, G.; Blanca, M.; Mayorga, C. Immunoglobulin Emediated immediate allergic reactions to dipyrone: value of basophil activation test in the identification of patients. Clin. Exp. Allergy, 2009, 39(8), 1217-1224.
19. Stern, R.S.; Bigby, M. An expanded profile of cutaneous reactions to nonsteroidal anti-inflammatory drugs. Reports to a specialtybased system for spontaneous reporting of adverse reactions to drugs. JAMA, 1984, 252(11), 1433-1437.
20. Mockenhaupt, M.; Viboud, C.; Dunant, A.; Naldi, L.; Halevy, S.; Bouwes Bavinck, J.N.;Sidoroff, A.; Schneck, J.; Roujeau, J.C.; Flahault, A. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J. Invest. Dermatol., 2008, 128(1), 35-44.
21. Layton, D.; Marshall, V.; Boshier, A.; Friedmann, P.; Shakir, S.A. Serious skin reactions and selective COX-2 inhibitors: a case series from prescription-event monitoring in England. Drug Saf., 2006, 29(8), 687-696.
22. Impicciatore, P.; Choonara, I.; Clarkson, A.; Provasi, D.; Pandolfini, C.; Bonati, M. Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br. J. Clin. Pharmacol., 2001, 52(1), 77-83.
23. Gomes, E.; Cardoso, M.F.; Praça, F.; Gomes, L.; Mariño, E.; Demoly, P. Self-reported drug allergy in a general adult Portuguese population. Clin. Exp. Allergy, 2004, 34(10), 1597-15601.
24. Sánchez-Borges, M.; Capriles-Hulett, A.; Caballero-Fonseca, F. Cutaneous reactions to aspirin and nonsteroidal antiinflammatory drugs. Clin. Rev. Allergy Immunol., 2003, 24(2), 125-36.v
25. Strom, B.L.; Carson, J.L.; Morse, M.L.; West, S.L.; Soper, K.A. The effect of indication on hypersensitivity reactions associated with zomepirac sodium and other nonsteroidal antiinflammatory drugs. Arthritis. Rheum., 1987, 30(10), 1142-1148.
26. Vane, J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New Biol., 1971, 231(25), 232-235.
27. Celik, G.; Bavbek, S.; Misirligil, Z.; Melli, M. Release of cysteinyl leukotrienes with aspirin stimulation and the effect of prostaglandin E(2) on this release from peripheral blood leucocytes in aspirininduced asthmatic patients. Clin. Exp. Allergy, 2001, 31(10), 1615-1622.
28. Szczeklik, A.; Sladek, K.; Dworski, R.; Nizankowska, E.; Soja, J.; Sheller, J.; Oates, J. Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics. Am. J. Respir. Crit. Care Med., 1996, 154(6 Pt1), 1608-1614.
29. Antczak, A.; Montuschi, P.; Kharitonov, S.; Gorski, P.; Barnes, P.J. Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma. Am. J. Respir. Crit. Care Med., 2002, 166(3), 301-306.
30. Sanak, M.; Kiełbasa, B.; Bochenek, G.; Szczeklik, A. Exhaled eicosanoids following oral aspirin challenge in asthmatic patients. Clin. Exp. Allergy, 2004, 34(12), 1899-1904.
31. Szczeklik, A.; Gryglewski, R.J.; Czerniawska-Mysik, G. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br. Med. J., 1975, 1(5949), 67-69.
32. Kowalski, M.L.; Bienkiewicz, B.P.K. Nasal polyposis in aspirinhypersensitive patients with asthma [aspirin triad] and aspirintolerant patients. Allergy Clin. Immunol. Int. - J. World Allergy Org., 2003, 6, 246-250.
33. Kowalski, M.L.; Pawliczak, R.; Wozniak, J.; Siuda, K.; Poniatowska, M.; Iwaszkiewicz, J.; Kornatowski, T.; Kaliner, M.A. Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients. Am. J. Respir. Crit. Care Med., 2000, 161(2 Pt 1), 391-398.
34. Szczeklik, A.; Nizankowska, E.; Duplaga, M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur. Respir. J., 2000, 16(3), 432-436.
35. Manfredi, G. Adverse drug reactions prevalence in south Italy. Allergy, 2008, 63, S110-111.
36. Carmona, M.J.; Blanca, M.; Garcia, A.; Fernandez, S.; Burgos, F.; Miranda, A.; Vega, J.M.; Garcia, J. Intolerance to piroxicam in patients with adverse reactions to nonsteroidal antiinflammatory drugs. J. Allergy Clin. Immunol., 1992, 90(6 Pt 1), 873-879.
37. Quiralte, J. Aspirin-induced isolated periorbital angioedema. Ann. Allergy Asthma Immunol., 1998, 81(5 Pt 1), 459.
38. Capriles-Behrens, E.; Caplin, J.; Sánchez-Borges, M. NSAID facial angioedema in a selected pediatric atopic population. J. Investig. Allergol. Clin. Immunol., 2000, 10(5), 277-279.
39. Moore-Robinson, M.; Warin, R.P. Effect of salicylates in urticaria. Br. Med. J., 1967, 4(5574), 262-624.
40. Asero, R.; Tedeschi, A.; Lorini, M. Autoreactivity is highly prevalent in patients with multiple intolerances to NSAIDs. Ann. Allergy Asthma Immunol., 2002, 88(5), 468-472.
41. Asero, R. Predictive value of autologous plasma skin test for multiple nonsteroidal anti-inflammatory drug intolerance. Int. Arch. Allergy Immunol., 2007, 144(3), 226-230.
42. Asero, R. Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria. J. Allergy Clin. Immunol., 2003, 111(5), 1095-1098.
43. Quiralte, J.; Blanco, C.; Delgado, J.; Ortega, N.; Alcantara, M.; Castillo, R.; Anguita, J.L.; Sáenz de San Pedro, B.; Carrillo, T. Challenge-based clinical patterns of 223 Spanish patients with nonsteroidal anti-inflammatory-drug-induced-reactions. J. Investig. Allergol. Clin. Immunol., 2007, 17(3), 182-188.
44. Patriarca, G.; Venuti, A.; Bonini, W. Allergy to pyramidon (aminopyrine). Ann. Allergy, 1973, 31(2), 84-86.
45. Lopatin, A.I.; Luzhniak, A.I.; Surmina, L.M. Anaphylactic shock from analgin. Klin. Med (Mosk), 1972, 50(6), 115-116.
46. Takahama, H.; Kubota, Y.; Mizoguchi, M. A case of anaphylaxis due to ibuprofen. J. Dermatol., 2000, 27(5), 337-340.
47. Gonzalez de Olano, D.; Gonzalez Mancebo, E.; Gandolfo Cano, M; Menendez Baltans, A.; Trujillo Trujillo, M.J. Flare-up-Like phenomenon in a skin prick test after oral challenge with ibuprofen. J. Investig. Allergol. Clin. Immunol., 2007, 17(6), 414-415.
48. Klote, M.M.; Smith, L.J. A case of anaphylaxis to naproxen. Allergy, 2005, 60(2), 260-261.
49. Mou, S.S.; Punaro, L.; Antan, J.; Luckett, P.M. Severe systemic hypersensitivity reaction to ibuprofen: a presentation of systemic lupus erythematosus. J. Rheumatol., 2006, 33(1), 171-172.
50. Stricker, B.H.; de Groot, R.R.M.; Wilson, J.H.P. Anaphylaxis to glafenine. Lancet, 1990, 336(8720), 943-4.
51. Stricker, B.H.; de Groot, R.R.; Wilson, J.H. Glafenine-associated anaphylaxis as a cause of hospital admission in The Netherlands. Eur. J. Clin. Pharmacol., 1991, 40(4), 367-371.
52. de Paramo, B.J.; Gancedo, S.Q.; Cuevas, M.; Camo, I.P.; Martin, J.A.; Cosmes, E.L. Paracetamol (acetaminophen) hypersensitivity. Ann. Allergy Asthma Immunol., 2000, 85(6 Pt 1), 508-511.
53. Kvedariene, V.; Bencherioua, A.M.; Messaad, D.; Godard, P.; Bousquet, J.; Demoly, P. The accuracy of the diagnosis of suspected paracetamol (acetaminophen) hypersensitivity: results of a single-blinded trial. Clin. Exp. Allergy, 2002, 32(9), 1366-1369.
54. Atzori, L.; Pinna, A.L.; Pau, M.; Aste, N.; Zucca, M.; Ferreli, C. Adverse cutaneous reactions to selective cyclooxygenase 2 inhibitors: experience of an Italian drug-surveillance center. J. Cutan. Med. Surg., 2006, 10(1), 31-35.
55. Fontaine, C.; Bousquet, P.J.; Demoly, P. Anaphylactic shock caused by a selective allergy to celecoxib, with no allergy to rofecoxib or sulfamethoxazole. J. Allergy Clin. Immunol., 2005, 115(3), 633-634.
56. Himly, M.; Jahn-Schmid, B.; Pittertschatscher, K.; Bohle, B.; Grubmayr, K.; Ferreira, F.; Ebner, H.; Ebner, C. IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone. J. Allergy Clin. Immunol., 2003, 111(4), 882-888.
57. Blanca, M.; Perez, E.; Garcia, J.J.; Miranda, A.; Terrados, S.; Vega, J.M.; Suau, R. Angioedema and IgE antibodies to aspirin: a case report. Ann. Allergy, 1989, 62(4), 295-298.
58. Rozieres, A.; Vocanson, M.; Saïd, B.B.; Nosbaum, A.; Nicolas, J.F. Role of T cells in nonimmediate allergic drug reactions. Curr. Opin. Allergy Clin. Immunol., 2009, 9(4), 305-310.
59. Fernández, T.D.; Canto, G.; Blanca, M. Molecular mechanisms of maculopapular exanthema. Curr. Opin. Infect. Dis., 2009, 22(3), 272-278.
60. Stein, K.R.; Scheinfeld, N.S. Drug-induced photoallergic and phototoxic reactions. Expert. Opin. Drug Saf., 2007, 6(4), 431-443.
61. Foti, C.; Cassano, N.; Conserva, A.; Vena, G.A. Allergic contact dermatitis due to diclofenac applied with iontophoresis. Clin. Exp. Dermatol., 2004, 29(1), 91.
62. Torres, M.J.; Mayorga, C.; Cornejo-Garcia, J.A.; Lopez, S.; Chaves, P.; Rondon, C.; Fernandez, T.; Blanca, M. Monitoring non-immediate allergic reactions to iodine contrast media. Clin. Exp. Immunol., 2008, 152(2), 233-238.
63. Torres, M.J.; Mayorga, C.; Fernández, T.D.; Cornejo-García, J.A.; Antúnez, C.; Valenzuela, M.; Del Prado, M.F.; Rodriguez-Pena, R.; Blanca, M. T cell assessment in allergic drug reactions during the acute phase according to the time of occurrence. Int. J. Immunopathol. Pharmacol., 2006, 19(1), 119-130.
64. Tsuge, I.; Okumura, A.; Kondo, Y.; Itomi, S.; Kakami, M.; Kawamura, M.; Nakajima, Y.; Komatsubara, R.; Urisu, A. Allergenspecific T-cell response in patients with phenytoin hypersensitivity; simultaneous analysis of proliferation and cytokine production by carboxyfluorescein succinimidyl ester (CFSE) dilution assay. Allergol. Int., 2007, 56(2), 149-155.
65. Yawalkar, N.; Egli, F.; Hari, Y.; Nievergelt, H.; Braathen, L.R.; Pichler, W.J. Infltration of cytotoxic T cells in drug-induced cutaneous eruptions. Clin. Exp. Allergy, 2000, 30(6), 847-855.
66. Hari, Y.; Urwyler, A.; Hurni, M.; Yawalkar, N.; Dahinden, C.; Wendland, T.; Braathen, L.R.; Matter, L.; Pichler, W.J. Distinct serum cytokine levels in drug- and measles-induced exanthema. Int. Arch. Allergy Immunol., 1999, 120(3), 225-229.
67. Posadas, S.J.; Leyva, L.; Torres, M.J.; Rodriguez, J.L.; Bravo, I.; Rosal, M.; Fernandez, J.; Juarez, C.; Blanca, M. Subjects with allergic reactions to drugs show polarized patterns of cytokine expression depending on the chronology of the clinical reaction. J. Allergy Clin. Immunol., 2000, 106(4), 769-776.
68. Fernandez, T.D.; Mayorga, C.; Torres, M.J.; Cornejo-Garcia, J.A.; López, S.; Chaves, P.; Rondon, C.; Blanca, M. Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs. Allergy, 2008, 63(6), 712-719.
69. Komatsu, T.; Moriya, N.; Shiohara, T. T cell receptor [TCR] repertoire and function of human epidermal T cells: restricted TCR V alpha-V beta genes are utilized by T cells residing in the lesional epidermis in fixed drug eruption. Clin. Exp. Immunol., 1996, 104(2), 343-350.
70. Shiohara, T.; Mizukawa Y. Fixed drug eruption: a disease mediated by self-inflicted responses of intraepidermal T cells. Eur. J. Dermatol., 2007, 17(3), 201-8.
71. Shiohara, T. Fixed drug eruption: pathogenesis and diagnostic tests. Curr. Opin. Allergy Clin. Immunol., 2009, 9(4), 316-321.
72. Shiohara, T.; Mizukawa, Y. Fixed drug eruption: easily overlooked but needing new respect. Dermatology, 2002, 205(2):103-4.
73. Senturk, N.; Yanik, F.; Yildiz, L.; Aydin, F.; Canturk, T.; Turanli, A.Y. Topotecan-induced celluitis-like fixed drug eruption. J. Eur. Acad. Dermatol. Venereol., 2002, 6(4), 14-16.
74. Sidoroff, A.; Halevy, S.; Bavinck, J.N.; Vaillant, L.; Roujeau, J.C. Acute generalized exanthematous pustulosis (AGEP) - a clinical reaction pattern. J. Cutan. Pathol., 2001, 28(3), 113-119.
75. Roujeau, J.C.; Bioulac-Sage, P.; Bourseau, C.; Guillaume, J.C.; Bernard, P.; Lok, C.; Plantin, P.; Claudy, A.; Delavierre, C.; Vaillant, L. Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch. Dermatol., 1991, 127(9), 1333-1338.
76. Britschgi, M.; Pichler, W.J. Acute generalized exanthematous pustulosis, a clue to neutrophil-mediated inflammatory processes orchestrated by T cells. Curr. Opin. Allergy Clin. Immunol., 2002, 2(4), 325-331.
77. Padial, M.A.; Alvarez-Ferreira, J.; Tapia, B.; Blanco, R; Mañas, C.; Blanca, M.; Bellón, T. Acute generalized exanthematous pustulosis associated with pseudoephedrine. Br. J. Dermatol., 2004, 150(1), 139-142.
78. Sidoroff, A.; Dunant, A.; Viboud, C.; Halevy, S.; Bavinck, J.N.; Naldi, L.; Mockenhaupt, M.; Fagot, J.P.; Roujeau, J.C. Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR). Br. J. Dermatol., 2007, 157(5), 989-996.
79. Gould, J.W.; Mercurio, M.G.; Elmets, C.A. Cutaneous photosensitivity diseases induced by exogenous agents. J. Am. Acad. Dermatol., 1995, 33(4), 551-573.
80. Castell, J.V.; Hernandez, D.; Gomez-Lechon, M. J.; Lahoz, A.; Miranda, M.A.; Morera, I.M.; Perez-Prieto, J.; Sarabia, Z. Photobinding of tiaprofenic acid and suprofen to proteins and cells: a combined study using radiolabeling, antibodies and laser flash photolysis of model bichromophores. Photochem. Photobiol., 1998, 68(5), 660-665.
81. Sarabia, Z.; Hernandez, D.; Castell, J.V.; van Henegouwen, G.M. Photoreactivity of tiaprofenic acid and suprofen using pig skin as an ex vivo model. J. Photochem. Photobiol. B., 2000, 58(1), 32-36.
82. Ljunggren, B. The piroxicam enigma. Photodermatology, 1989, 6(4), 151-153.
83. Vargas, F.; Rivas, C.; Zoltan, T.; Fuentes, A.; Padron, L.; Diaz, Y.; Izzo, C. Photodegradation and in vitro phototoxicity of aceclofenac. Die Pharmazie, 2007, 62(5), 337-341.
84. Castell, J.V.; Castell, M. Allergic hepatitis induced by drugs. Curr. Opin. Allergy Clin. Immunol., 2006, 6(4), 258-265.
85. Hannequin, J.R.; Doffoel, M.; Schmutz, G. Hepatitis secondary to current non-steroidal anti-inflammatory agents. Rev. Rhum. Mal. Osteoartic., 1988, 55(12), 983-988.
86. Herdeg, C.; Hilt, F.; Büchtemann, A.; Bianchi, L.; Klein, R. Allergic cholestatic hepatitis and exanthema induced by metamizole: verification by lymphocyte transformation test. Liver, 2002, 22(6), 507-513.
87. de Valle, M.B.; Av Klinteberg, V.; Alem, N.; Olsson, R.; Björnsson, E. Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic. Aliment. Pharmacol. Ther., 2006, 24(8), 1187-1195.
88. Mayoral, W.; Lewis, J.H.; Zimmerman, H. Drug-induced liver disease. Curr. Opin. Gastroenterol., 1999, 15(3), 208-216.
89. Arundel, C.; Lewis, J.H. Drug-induced liver disease in 2006. Curr. Opin. Gastroenterol., 2007, 23(3), 244-254.
90. Allen, J.N. Drug-induced eosinophilic lung disease. Clin. Chest Med., 2004, 25(1), 77-88.
91. Szczeklik, A.; Nizankowska-Mogilnicka, E.; Sanak, M. In Middleton's Allergy. Principles & Practice; Adkinson, N.F.; Brochneer, B.S.; Busse, S.T.; Holgate, R.F.; Lemanske, R.F.; Simons, E.R.; Ed.; Mosby Elsevier, USA, 2009, pp. 1227-1243.
92. Bousquet, P.J.; Demoly, P.; Romano, A.; Aberer, W.; Bircher, A.; Blanca, M.; Brockow, K.; Pichler, W.; Torres, M.J.; Terreehorst, I.; Arnoux, B.; Atanaskovic-Markovic, M.; Barbaud, A.; Bijl, A.; Bonadonna, P.; Burney, P.G.; Caimmi, S.; Canonica, G.W.; Cernadas, J.; Dahlen, B.; Daures, J.P.; Fernandez, J.; Gomes, E.; Gueant, J.L.; Kowalski, M.L.; Kvedariene, V.; Mertes, P.M.; Martins, P.; Nizankowska-Mogilnicka, E.; Papadopoulos, N.; Ponvert, C.; Pirmohamed, M.; Ring, J.; Salapatas, M.; Sanz, M.L.; Szczeklik, A.; Van Ganse, E.; De Weck, A.L.; Zuberbier, T.; Merk, H.F.; Sachs, B.; Sidoroff, A.; Global Allergy, Asthma European Network (GALEN) and Drug Allergy and Hypersensitivity Database (DAHD) and the European Network for Drug Allergy (ENDA). Pharmacovigilance of drug allergy and hypersensitivity using the ENDA-DAHD database and the GALEN platform. The Galenda project. Allergy, 2009, 64(2),194-203.
93. Yoshimine, F.; Hasegawa, T.; Suzuki, E.; Terada, M.; Koya, T.; Kondoh, A.; Arakawa, M.; Yoshizawa, H.; Gejvo, F. Contribution of aspirin-intolerant asthma to near fatal asthma based on a questionnaire survey in Niigata Prefecture, Japan. Respirology, 2005, 10(4), 477-484.
94. Berges-Gimeno, M.P.; Simon, R.A.; Stevenson, D.D. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann. Allergy Asthma Immunol., 2002, 89(5), 474-478.
95. Nizankowska-Mogilnicka, E.; Bochenek, G.; Mastalerz, L.; Swierczyńska, M.; Picado, C.; Scadding, G.; Kowalski, M.L.; Setkowicz, M.; Ring, J.; Brockow, K.; Bachert, C.; Wöhrl, S.; Dahlén, B.; Szczeklik, A. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy, 2007, 62(10), 1111-1118.
96. Alonso-Llamazares. A.;, Martinez-Cócera, C.; Domínguez- Ortega, J.; Robledo-Echarren, T.; Cimarra-Alvarez, M.; Mesa del Castillo, M. Nasal provocation test (NPT) with aspirin: a sensitive and safe method to diagnose aspirin-induced asthma (AIA). Allergy, 2002, 57(7), 632-635.
97. Milewski, M.; Mastalerz, L.; Nizankowska, E.; Szczeklik, A. Nasal provocation test with lysine-aspirin for diagnosis of aspirinsensitive asthma. J. Allergy Clin. Immunol., 1998, 101(5), 581-586.
98. Hassani, A.; Ponvert, C.; Karila, C.; Le Bourgeois, M.; De Blic, J.; Scheinmann, P. Hypersensitivity to cyclooxygenase inhibitory drugs in children: a study of 164 cases. Eur. J. Dermatol., 2008, 18(5), 561-565.
99. Liccardi, G.; Cazzola, M.; De Giglio, C.; Manfredi, D.; Piscitelli, E.; D'Amato, M.; D'Amato, G. Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and other non-steroidal anti-inflammatory drugs. J. Investig. Allergol. Clin. Immunol., 2005, 15(4), 249-253.
100. Bochenek. G.; Nizankowska, E.; Szczeklik, A. Testing for aspirin hypersensitivity. Allergy, 2002, 57(7), 562-565.
101. Cormican, L.J.; Farooque, S.; Altmann, D.R.; Lee, T.H. Improvements in an oral aspirin challenge protocol for the diagnosis of aspirin hypersensitivity. Clin. Exp. Allergy, 2005, 35(6),717-722.
102. Plaza, V.; Serrano, J.; Picado, C.; Sanchis, J. Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma. Eur. Respir. J., 2002, 19(5), 846-852.
103. Kowalski, M.L.; Bienkiewicz, B.; Woszczek, G.; Iwaszkiewicz, J.; Poniatowska, M. Diagnosis of pyrazolone drug sensitivity: clinical history versus skin testing and in vitro testing. Allergy Asthma Proc., 1999, 20(6), 347-352.
104. Bienkiewicz, B.; Kowalski, M.L. Clinical patterns and diagnosis of hypersensitivity reactions to pyrazolone drugs. XXIII EAACI Congress Abstract Book 2004; p. 316.
105. Sanz, M.L.; Gamboa, P.; de Weck, A.L. A new combined test with flowcytometric basophil activation and determination of sulfidoleukotrienes is useful for in vitro diagnosis of hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs. Int. Arch. Allergy Immunol., 2005, 136(1), 58-72.
106. Czech, W.; Schopf, E.; Kapp, A. Release of sulfidoleukotrienes in vitro: its relevance in the diagnosis of pseudoallergy to acetylsalicylic acid. Inflamm. Res., 1995, 44(2), 291-295.
107. May, A.; Weber, A.; Gall, H.; Kaufmann, R.; Zollner, T.M. Means of increasing sensitivity of an in vitro diagnostic test for aspirin intolerance. Clin. Exp. Allergy, 1999, 29(10), 1402-1411.
108. Gamboa, P.; Sanz, M.L.; Caballero, M.R.; Urrutia, I.; Antepara, I.; Esparza, R.; de Weck, A.L. The flow-cytometric determination of basophil activation induced by aspirin and other non-steroidal antiinflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome. Clin. Exp. Allergy, 2004, 34(9), 1448-1457.
109. Kowalski, M.L.; Ptasinska, A.; Jedrzejczak, M.; Bienkiewicz, B.; Cieslak, M.; Grzegorczyk, J.; Pawliczak, R.; Dubusque, L. Aspirintriggered 15-HETE generation in peripheral blood leukocytes is a specific and sensitive Aspirin-Sensitive Patients Identification Test (ASPITest). Allergy, 2005, 60(9), 1139-1145.
110. Kowalski, M.L.; Pawliczak, R.; Wozniak, J.; Siuda, K.; Poniatowska, M.; Iwaszkiewicz, J.; Kornatowski, T.; Kaliner, M.A. Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients. Am. J. Respir. Crit. Care Med., 2000, 161(2 Pt 1), 391-398.
111. Barbaud, A. Skin testing in delayed reactions to drugs. Immunol. Allergy Clin. North Am., 2009, 29(3), 517-535.
112. Padial, A.; Antunez, C.; Blanca-Lopez, N.; Fernandez, T.D.; Cornejo-Garcia, J.A.; Mayorga, C.; Torres, M.J.; Blanca, M. Nonimmediate reactions to beta-lactams: diagnostic value of skin testing and drug provocation test. Clin. Exp. Allergy, 2008, 38(5), 822-828.
113. Pichler, W.J.; Tilch, J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy, 2004, 59(8), 809-820.
114. Hackstein, H.; Morelli, A.E.; Larregina, A.T.; Ganster, R.W.; Papworth, G.D.; Logar, A.J.; Watkins, S.C.; Falo, L.D.; Thomson, A.W. Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells. J. Immunol., 2001, 166(12), 7053-7062.
115. Posadas, S.J.; Torres, M.J.; Mayorga, C.; Juarez, C.; Blanca M. Gene expression levels of cytokine profile and cytotoxic markers in non-immediate reactions to drugs. Blood Cells Mol. Dis., 2002, 29(2), 179-189.
116. Posadas, S.J.; Padial, A.; Torres, M.J.; Mayorga, C.; Leyva, L.; Sanchez, E.; Alvarez, J.; Romano, A.; Juarez, C.; Blanca, M. Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity. J. Allergy Clin. Immunol., 2002, 109(1), 155-161.
117. Mastalerz, L.; Setkowicz, M.; Sanak, M.; Szczeklik, A. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. J. Allergy Clin. Immunol., 2004, 113(4), 771-775.
118. Mastalerz, L.; Setkowicz, M.; Sanak, M.; Rybarczyk, H.; Szczeklik, A. Familial aggregation of aspirin-induced urticaria and leukotriene C synthase allelic variant. Br. J. Dermatol., 2006, 154(2), 256-260.
119. Torres-Galván, M.J.; Ortega, N.; Sánchez-García, F.; Blanco, C.; Carrillo, T.; Quiralte, J. LTC4-synthase A-444C polymorphism: lack of association with NSAID-induced isolated periorbital angioedema in a Spanish population. Ann. Allergy Asthma Immunol., 2001, 87(6), 506-510.
120. Kim, S.H.; Choi, J.H.; Holloway, J.W.; Suh, C.H.; Nahm, D.H.; Ha, E.H.; Park, C.S.; Park, H.S. Leukotriene-related gene polymorphisms in patients with ASA induced urticaria and ASA-intolerant asthma: differing contributions of ALOX5 polymorphism in Korean population. J. Korean Med. Sci., 2005, 20(6), 926-931.
121. Kim, S.H.; Oh, J.M.; Kim, Y.S.; Palmer, L.J.; Suh, C.H.; Nahm, D.H.; Park, H.S. Cysteinyl leukotriene receptor 1 promoter polymorphism is associated with aspirin-intolerant asthma in males. Clin. Exp. Allergy, 2006, 36(4), 433-439.
122. Choi, J.H.; Park, H.S.; Oh, H.B.; Lee, J.H.; Suh, Y.J.; Park, C.S.; Shin, H.D. Leukotriene-related gene polymorphisms in ASAintolerant asthma: an association with a haplotype of 5-lipoxygenase. Hum. Genet., 2004, 114(4), 337-344.
123. Kim, S.H.; Yang, E.M.; Park, H.J.; Ye, Y.M.; Lee, H.Y.; Park, H.S. Differential contribution of the CyslTR1 in patients with aspirin hypersensitivity. J. Clin. Immunol., 2007, 27(6), 613-619.
124. Park, J.S.; Chang, H.S.; Park, C.S.; Lee, J.H.; Lee, Y.M.; Choi, J.H.; Park, H.S.; Kim, L.H.; Park, B.L.; Choi, Y.H.; Shin, H.D. Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics. Pharmacogenet. Genomics, 2005, 15(7), 483-492.
125. Choi, J.H.; Lee, K.W.; Oh, H.B.; Lee, K.J.; Suh, Y.J.; Park, C.S.; Park, H.S. HLA association in aspirin-intolerant asthma: DPB1*0301 as a strong marker in a Korean population. J. Allergy Clin. Immunol., 2004, 113(3), 562-564.
126. Park, H.S.; Kim, S.H.; Sampson, A.P.; Lee, K.W.; Park, C.S. The HLA-DPB1*0301 marker might predict the requirement for leukotriene receptor antagonist in patients with aspirin-intolerant asthma. J. Allergy Clin. Immunol., 2004, 114(3), 688-689.
127. Kim, S.H.; Choi, J.H.; Lee, K.W.; Kim, S.H.; Shin, E.S.; Oh, H.B.; Suh, C.H.; Nahm, D.H.; Park, H.S. The HLA-DRB1*1302-DQB1*0609- DPB1*0201 haplotype may be a strong genetic marker for aspirin-induced urticaria. Clin. Exp. Allergy, 2005, 35(3), 339-344.
128. Bae, J.S.; Kim, S.H.; Ye, Y.M.; Yoon, H.J.; Suh, C.H.; Nahm, D.H.; Park, H.S. Significant association of FcepsilonRIalpha promoter polymorphisms with aspirin-intolerant chronic urticaria. J. Allergy Clin. Immunol., 2007, 119(2), 449-456.
129. Choi, J.H.; Kim, S.H.; Suh, C.H.; Nahm, D.H.; Park, H.S. Polymorphisms of high-affinity IgE receptor and histamine-related genes in patients with ASA-induced urticaria/angioedema. J. Korean Med. Sci., 2005, 20(3), 367-372.
130. Palikhe, N.S.; Kim, S.H.; Cho, B.Y.; Ye, Y.M.; Hur, G.Y.; Park, H.S. Association of three sets of high-affinity IgE receptor (FcepsilonR1) polymorphisms with aspirin-intolerant asthma. Respir Med, 2008, 102(8), 1132-1139.
131. Kim, S.H.; Yang, E.M.; Lee, H.N.; Cho, B.Y.; Ye, Y.M.; Park HS. Combined effect of IL-10 and TGF-beta1 promoter polymorphisms as a risk factor for aspirin-intolerant asthma and rhinosinusitis. Allergy, 2009, 64(8), 1221-1225.
132. Choi, J.H., Kim, S.H., Cho, B.Y.; Lee, S.K.; Kim, S.H.; Suh, C.H.; Park, H.S. Association of TNF-alpha promoter polymorphisms with aspirin-induced urticaria. J. Clin. Pharm. Ther., 2009, 34(2), 231-238.
133. Kim, S.H.; Kang, Y.M.; Kim, S.H.; Cho, B.Y.; Ye, Y.M.; Hur, G.Y.; Park, H.S. Histamine N-methyltransferase 939A>G polymorphism affects mRNA stability in patients with acetylsalicylic acid-intolerant chronic urticaria. Allergy, 2009, 64(2), 213-221.
134. Garcia-Martin, E.; Ayuso, P.; Martinez, C.; Agundez, J.A. Improved analytical sensitivity reveals the occurrence of genderrelated variability in diamine oxidase enzyme activity in healthy individuals. Clin. Biochem., 2007, 40(16-17), 1339-1341.
135. Ayuso, P.; Garcia-Martin, E.; Martinez, C.; Agundez, J.A. Genetic variability of human diamine oxidase: occurrence of three nonsynonymous polymorphisms and study of their effect on serum enzyme activity. Pharmacogenet. Genomics, 2007, 17(9), 687-693.
136. Garcia-Martin, E.; Ayuso, P.; Martinez, C.; Blanca, M.; Agundez, J.A. Histamine pharmacogenomics. Pharmacogenomics, 2009, 10(5), 867-883.
137. Garcia-Martin, E.; Mendoza, J.L.; Martinez, C.; Taxonera, C.; Urcelay, E.; Ladero, J.M.; de la Concha, E.G.; Diaz-Rubio, M.; Agundez, J.A. Severity of ulcerative colitis is associated with a polymorphism at diamine oxidase gene but not at histamine Nmethyltransferase gene. World J. Gastroenterol., 2006, 12(4), 615-620.
138. Garcia-Martin, E.; Garcia-Menaya, J.; Sanchez, B.; Martinez, C.; Rosendo, R.; Agundez, J.A. Polymorphisms of histaminemetabolizing enzymes and clinical manifestations of asthma and allergic rhinitis. Clin. Exp. Allergy, 2007, 37(8), 1175-1182.
139. Garcia-Martin, E.; Ayuso, P.; Luengo, A.; Martinez, C.; Agundez, J.A. Genetic variability of histamine receptors in patients with Parkinson's disease. BMC Med. Genet., 2008, 9, 15.
140. Garcia-Martin, E.; Martinez, C.; Serrador, M.; Alonso-Navarro, H.; Navacerrada, F.; Agundez, J.A.; Jimenez-Jimenez, F.J. Histamine-N-methyl transferase polymorphism and risk for migraine. Headache, 2008, 48(9), 1343-1348.
141. Agundez, J.A.; Luengo, A.; Herraez, O.; Martinez, C.; Alonso-Navarro, H.; Jimenez-Jimenez, F.J.; Garcia-Martin, E. Nonsynonymous polymorphisms of histamine-metabolising enzymes in patients with Parkinson's disease. Neuromolecular Med., 2008, 10(1), 10-16.
142. Garcia-Martin, E.; Martinez, C.; Benito-Leon, J.; Calleja, P.; Diaz-Sanchez, M.; Pisa, D.; Alonso-Navarro, H.; Ayuso-Peralta, L.; Torrecilla, D.; Agundez, J.A.; Jimenez-Jimenez, F.J. Histamine-Nmethyl transferase polymorphism and risk for multiple sclerosis. Eur. J. Neurol., 2009 (Epub ahead of print).
143. Kim, S.H.; Kim, Y.K.; Park, H.W.; Kim, S.H.; Kim, S.H.; Ye, Y.M.; Min, K.U.; Park, H.S. Adenosine deaminase and adenosine receptor polymorphisms in aspirin-intolerant asthma. Respir. Med., 2009, 103(3), 356-363.